ASX - By Stock
|
ATH |
Re:
What does the QSM signal measure ?
|
|
pivalde
|
2 |
1.0K |
1 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
2
|
1.0K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
What does the QSM signal measure ?
|
|
pivalde
|
2 |
1.0K |
4 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
2
|
1.0K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Good to look at the reference study by Wenning et al
|
|
pivalde
|
8 |
2.5K |
10 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
8
|
2.5K
|
10
|
|
ASX - By Stock
|
ATH |
Re:
Good to look at the reference study by Wenning et al
|
|
pivalde
|
8 |
2.5K |
6 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
8
|
2.5K
|
6
|
|
ASX - By Stock
|
ATH |
Good to look at the reference study by Wenning et al
|
|
pivalde
|
8 |
2.5K |
8 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
8
|
2.5K
|
8
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Proposed issue of securities - ATH
|
|
pivalde
|
1 |
706 |
1 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
1
|
706
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial
|
|
pivalde
|
168 |
47K |
10 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
168
|
47K
|
10
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial
|
|
pivalde
|
168 |
47K |
4 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
168
|
47K
|
4
|
|
ASX - By Stock
|
ATH |
New eye paper by Finkelstein et al
|
|
pivalde
|
0 |
262 |
5 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
0
|
262
|
5
|
|
ASX - By Stock
|
ATH |
Shorts are careful as are the other investors
|
|
pivalde
|
3 |
1.0K |
3 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
3
|
1.0K
|
3
|
|
ASX - By Stock
|
ATH Biotech |
Re:
JULY IS HERE !!!
|
|
pivalde
|
79 |
21K |
5 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
79
|
21K
|
5
|
|
ASX - By Stock
|
ATH Biotech |
Re:
JULY IS HERE !!!
|
|
pivalde
|
79 |
21K |
4 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
79
|
21K
|
4
|
|
ASX - By Stock
|
ATH Biotech |
Re:
JULY IS HERE !!!
|
|
pivalde
|
79 |
21K |
3 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
79
|
21K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
36 genes related to iron in brain
|
|
pivalde
|
4 |
1.7K |
6 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
4
|
1.7K
|
6
|
|
ASX - By Stock
|
ATH |
36 genes related to iron in brain
|
|
pivalde
|
4 |
1.7K |
6 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
4
|
1.7K
|
6
|
|
ASX - By Stock
|
ATH |
Synucleinopathy: inpact on lipids of mitochondria and ER
|
|
pivalde
|
0 |
283 |
2 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
0
|
283
|
2
|
|
ASX - By Stock
|
ATH |
Prevalence of PD increasing
|
|
pivalde
|
0 |
199 |
2 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
0
|
199
|
2
|
|
ASX - By Stock
|
ATH |
Bacteria triggering inflammation contributes to PD ????
|
|
pivalde
|
5 |
1.4K |
3 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
5
|
1.4K
|
3
|
|
ASX - By Stock
|
ATH |
Coffee, tobacco and asperin delays getting PD
|
|
pivalde
|
4 |
1.1K |
2 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
4
|
1.1K
|
2
|
|
ASX - By Stock
|
ATH |
What does the QSM signal measure ?
|
|
pivalde
|
2 |
1.0K |
6 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
2
|
1.0K
|
6
|
|
ASX - By Stock
|
ATH |
Iron in clinical subtypes of MSA
|
|
pivalde
|
0 |
339 |
9 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
0
|
339
|
9
|
|
ASX - By Stock
|
ATH |
Re:
Forebrain atrophy in early AD, by Masters et al
|
|
pivalde
|
19 |
4.8K |
4 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
19
|
4.8K
|
4
|
|
ASX - By Stock
|
ATH |
Link Between Anxiety/Depression and Alzheimer's Dementia
|
|
pivalde
|
0 |
262 |
4 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
0
|
262
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Forebrain atrophy in early AD, by Masters et al
|
|
pivalde
|
19 |
4.8K |
5 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
19
|
4.8K
|
5
|
|
ASX - By Stock
|
ATH |
Forebrain atrophy in early AD, by Masters et al
|
|
pivalde
|
19 |
4.8K |
3 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
19
|
4.8K
|
3
|
|
ASX - By Stock
|
ATH |
Short activity
|
|
pivalde
|
9 |
2.5K |
6 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
9
|
2.5K
|
6
|
|
ASX - By Stock
|
ATH |
Ferroptosis in neuroimmune and degenerative diseases
|
|
pivalde
|
0 |
381 |
3 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
0
|
381
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Iron accumulation and non-dopamine neurotransmitters
|
|
pivalde
|
2 |
618 |
2 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
2
|
618
|
2
|
|
ASX - By Stock
|
ATH |
Iron accumulation and non-dopamine neurotransmitters
|
|
pivalde
|
2 |
618 |
3 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
2
|
618
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Webcast Today - New Data from bioMUSE Natural History Study
|
|
pivalde
|
72 |
21K |
5 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
72
|
21K
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Webcast Today - New Data from bioMUSE Natural History Study
|
|
pivalde
|
72 |
21K |
5 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
72
|
21K
|
5
|
|
ASX - By Stock
|
ATH |
Parkinson's in autistic people
|
|
pivalde
|
0 |
287 |
4 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
0
|
287
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Why deferiprone did not work in PD
|
|
pivalde
|
13 |
3.7K |
3 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
13
|
3.7K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Iron, a causal factor in PD and non-Alzheimer dementia
|
|
pivalde
|
1 |
447 |
1 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
1
|
447
|
1
|
|
ASX - By Stock
|
ATH |
Iron, a causal factor in PD and non-Alzheimer dementia
|
|
pivalde
|
1 |
447 |
3 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
1
|
447
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Why deferiprone did not work in PD
|
|
pivalde
|
13 |
3.7K |
7 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
13
|
3.7K
|
7
|
|
ASX - By Stock
|
ATH |
Re:
Why deferiprone did not work in PD
|
|
pivalde
|
13 |
3.7K |
4 |
26/05/24 |
26/05/24 |
ASX - By Stock
|
13
|
3.7K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Why deferiprone did not work in PD
|
|
pivalde
|
13 |
3.7K |
10 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
13
|
3.7K
|
10
|
|
ASX - By Stock
|
ATH |
Re:
The next experimental eye study by Finkelstein el al
|
|
pivalde
|
1 |
600 |
3 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
1
|
600
|
3
|
|
ASX - By Stock
|
ATH |
The next experimental eye study by Finkelstein el al
|
|
pivalde
|
1 |
600 |
5 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
1
|
600
|
5
|
|
ASX - By Stock
|
ATH |
Re:
Comorbidities with AD, by Masters et al
|
|
pivalde
|
3 |
980 |
2 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
3
|
980
|
2
|
|
ASX - By Stock
|
ATH |
Comorbidities with AD, by Masters et al
|
|
pivalde
|
3 |
980 |
1 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
3
|
980
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Why deferiprone did not work in PD
|
|
pivalde
|
13 |
3.7K |
4 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
13
|
3.7K
|
4
|
|
ASX - By Stock
|
ATH |
Why deferiprone did not work in PD
|
|
pivalde
|
13 |
3.7K |
7 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
13
|
3.7K
|
7
|
|
ASX - By Stock
|
ATH |
Re:
What did Prof. Kosman tell almost 3 y ago?
|
|
pivalde
|
5 |
1.3K |
1 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
5
|
1.3K
|
1
|
|
ASX - By Stock
|
ATH |
What did Prof. Kosman tell almost 3 y ago?
|
|
pivalde
|
5 |
1.3K |
5 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
5
|
1.3K
|
5
|
|
ASX - By Stock
|
ATH |
Iron / risk of dementia
|
|
pivalde
|
0 |
367 |
8 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
0
|
367
|
8
|
|
ASX - By Stock
|
ATH |
iron status as a risk of cardiomyopathy
|
|
pivalde
|
1 |
485 |
4 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
1
|
485
|
4
|
|
ASX - By Stock
|
ATH |
Conclusions of Dr. Pall, Prof. Kosman and the "Stanford scientists
|
|
pivalde
|
1 |
480 |
7 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
1
|
480
|
7
|
|
ASX - By Stock
|
ATH |
Re:
"How organs accumulate extra iron" by Kosman
|
|
pivalde
|
3 |
1.0K |
3 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
3
|
1.0K
|
3
|
|